These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37893599)

  • 1. Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study.
    Tsiachris D; Papakonstantinou PE; Doundoulakis I; Tsioufis P; Botis M; Dimitriadis K; Leontsinis I; Kordalis A; Antoniou CK; Mantzouranis E; Iliakis P; Vlachakis PK; Gatzoulis KA; Tsioufis K
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893599
    [No Abstract]   [Full Text] [Related]  

  • 2. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke prevention of thoracoscopic left atrial appendage clipping in patients with non-valvular atrial fibrillation at high risk of stroke and bleeding: study protocol for a non-randomised controlled clinical trial.
    Ye C; Han X; Chen Y; Liu F; Ma H; Yang Y; Liu Y; Hu Q; Yao Q; Xie W; Xu D
    BMJ Open; 2022 Oct; 12(10):e063931. PubMed ID: 36307161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Left Atrial Appendage Closure and Oral Anticoagulation After Atrial Fibrillation Catheter Ablation.
    Fei ZT; Yao PC; Qiu JH; Chen M; Fei YD; Li W; Zhang PP; Sun J; Wang QS; Li YG
    Am J Cardiol; 2023 Oct; 204():312-319. PubMed ID: 37567023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion.
    Li W; Gao R; Zhao J; Ren Y; Chen G; Zhu J; Jin K; Zhu L; Ruan Z
    Ann Palliat Med; 2022 Jan; 11(1):201-209. PubMed ID: 35144411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
    Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
    Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of combined catheter ablation and left atrial appendage closure for symptomatic atrial fibrillation in patients with high stroke and bleeding risk.
    Kawakami H; Nolan MT; Phillips K; Scuffham PA; Marwick TH
    Am Heart J; 2021 Jan; 231():110-120. PubMed ID: 32822655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
    Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M
    Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.
    Masjuan J; Salido L; DeFelipe A; Hernández-Antolín R; Fernández-Golfín C; Cruz-Culebras A; Matute C; Vera R; Pérez-Torre P; Zamorano JL
    Eur J Neurol; 2019 May; 26(5):816-820. PubMed ID: 30586229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Updated Meta-Analysis on the Clinical Outcomes of Percutaneous Left Atrial Appendage Closure Versus Direct Oral Anticoagulation in Patients With Atrial Fibrillation.
    Jiang H; Koh TH; Vengkat V; Fei G; Ding ZP; Ewe SH; Jappar I; Lim ST; Yap J
    Am J Cardiol; 2023 Aug; 200():135-143. PubMed ID: 37321026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less major bleeding and higher hemoglobin after left atrial appendage closure in high-risk patients: Data from a long-term, longitudinal, two-center observational study.
    Schach C; Reitschuster R; Benedikt D; Füssl E; Debl K; Maier LS; Luchner A
    Clin Cardiol; 2023 Nov; 46(11):1337-1344. PubMed ID: 37573576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Atrial Appendage Occlusion for Secondary Stroke Prevention in Patients with Atrial Fibrillation: Long-Term Results.
    Litwinowicz R; Bartus M; Malec-Litwinowicz M; Michalski M; Banaszkiewicz K; Kapelak B; Lakkireddy D; Bartus K
    Cerebrovasc Dis; 2019; 47(3-4):188-195. PubMed ID: 31121584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcome of patients with left atrial appendage closure in China: a single-center experience.
    Zhang J; Li C; Zhou L; Sang C; Li S; Ma C
    BMC Cardiovasc Disord; 2024 Feb; 24(1):108. PubMed ID: 38355458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry.
    Phillips KP; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2020 Feb; 22(2):225-231. PubMed ID: 31665276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
    Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
    Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Left Atrial Appendage Closure in Patients with Non-Valvular Atrial Fibrillation and End-Stage Renal Disease on Hemodialysis: A Case Series.
    Basabe E; De La Flor JC; López de la Manzanara V; Nombela-Franco L; Narváez-Mejía C; Cruzado L; Villa D; Zamora R; Tapia M; Sastre MÁ; López Soberón E; Herrero Calvo JA; Suárez A; Martí Sánchez D
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.